Saccharomyces boulardii'. A review of an innovative biotherapeutic agent

174Citations
Citations of this article
133Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Saccharomyces boulardii is a non-pathogenic yeast which has been used as both a preventive and therapeutic agent for the treatment of a variety of diarrhoeal diseases. The studies with animal models and evidence from human volunteers and patients indicate a profile which is effective in the therapy of diarrhoea and is remarkably safe for oral ingestion. The pharmacokinetic data demonstrate that 5. boulardü reaches a steady-state concentration quickly and maintains a high stable level as long as the yeast is taken daily. Once the agent is discontinued, S. boulardü is quickly eliminated from the colon. Clinical trials studying antibiotic-associated diarrhoea, nasogastric-tube alimentation diarrhoea, Clostridium difficile-disease, acute diarrhoea and chronic diarrhoea in HI V-infected patients are reviewed. ©1993 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

Cite

CITATION STYLE

APA

Mcfarland, L. V., & Bernasconi, P. (1993). Saccharomyces boulardii’. A review of an innovative biotherapeutic agent. Microbial Ecology in Health and Disease, 6(4), 157–171. https://doi.org/10.3109/08910609309141323

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free